CARB-X portfolio
31 tracked investments, 4 on the map, $471M raised across the mapped portfolio.
CARB-X31 investments · 4 on the map · $471M raised- Vedanta BiosciencesGrant
- LimmaTech Biologics
- Melinta TherapeuticsGrant
- Melio
Also in the portfolio
- Debiopharm Group
- BioVersys
- Locus Biosciences
- Shionogi
- Cellics Therapeutics
- Day Zero Diagnostics
- University of Edinburgh
- Macro Biologics
- Affinivax
- Eligo Bioscience
- Centauri Therapeutics
- Baebies
- Idorsia
- Venatorx Pharmaceuticals
- Iterum Therapeutics
- Spero Therapeutics
- GlaxoSmithKline
- Oxford Drug Design
- Basilea Pharmaceutica
- GenomeKey
- Helmholtz Centre for Infection Research
- Accelerate Diagnostics
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
- ContraFect
- Entasis Therapeutics
- Tetraphase Pharmaceuticals
- University of Queensland
Investors similar to CARB-X
Accel599 investments · 483 on the map · $23.8B raised
General Catalyst494 investments · 410 on the map · $33.6B raised
SOSV384 investments · 361 on the map · $1.9B raised
Bessemer Venture Partners437 investments · 353 on the map · $213.8B raised
Salesforce Ventures335 investments · 242 on the map · $8.5B raised
Coatue215 investments · 111 on the map · $30.3B raised